
NANO-X IMAGING LTD
NNOXNASDAQTrading Snapshot
- Day Range
- $1.10 β $1.12
- 52-Week Range
- $0.73 β $4.88
- Volume
- $2.76B
- Avg Volume
- $3.08B
- Shares Outstanding
- 69.6M
- Next Earnings
- Oct 16, 2026
Fundamentals Snapshot
- Annual Revenue
- $13M
- Last Q Revenue
- $4M
- P/E Ratio
- β
- P/S Ratio
- 5.1x
- EPS (TTM)
- $-1.15
- Dividend Yield
- β
Why Investors Own NNOX
- βHigh-growth profile β revenue up -4.2% YoY with expanding US Equity exposure.
- βHealthy economics β 51% gross margin and 19% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About NANO-X IMAGING LTD
Nano-X Imaging Ltd. specializes in developing a commercial-grade tomographic imaging device that incorporates an innovative digital X-ray source, which leverages a digital micro-electro-mechanical systems (MEMS) semiconductor cathode. Beyond its hardware focus, the company also delivers teleradiology services and creates artificial intelligence (AI) applications tailored for practical use in medical imaging. Its core offerings include the Nanox.ARC, a prototype medical imaging system that integrates its proprietary digital X-ray technology, and Nanox.CLOUD, a complementary cloud-based software platform envisioned to facilitate medical screening as a service. Nano-X also operates Nanox.MARKETPLACE, a platform designed to connect imaging facilities and customers with radiologists for efficient remote interpretation of medical scans. Additionally, the company provides AI-driven software solutions to a wide range of healthcare entities, including hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers. These solutions are designed to analyze data from existing computed tomography (CT) scans to identify or predict undiagnosed or underdiagnosed medical conditions, such as osteoporosis and cardiovascular disease. Nano-X further offers Teleradiology Services, delivering remote imaging interpretation to radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities, and multi-specialty physician groups. Founded in 2011, Nano-X Imaging Ltd. is headquartered in Neve Ilan, Israel.
Otter Score Breakdown
βAnalyst Ratings
βLatest News & Updates
Nano-X Imaging CEO And Director Erez Meltzer Buys 9,443 Ordinary Shares At $1.03 Per Share
https://www.sec.gov/Archives/edgar/data/1371973/000121390026087547/xslF345X06/ownership.xml
Nanox AI Optimizes Medical Imaging AI For On-Premise Edge Inference With Intel Core Ultra And OpenVINO
On-premise medical imaging AI framework uses Intel Core Ultra processors and Intelβs OpenVINO toolkit to accelerate edge inference within healthcare environmentsPETACH TIKVA, Israel β August 10 β Nanox AI Ltd., a
Nano-X Imaging Prices Placement Of 8M Shares And Warrants To A Long-Term Institutional Investor At $1.00 Per Unit
The warrants will have an exercise price of $1.15 per Ordinary Share, will be exercisable six months following issuance and will expire five years from the closing date. The closing of the Offering is expected to occur